Total Funding
58
33
Total FundingSeed raised
Growth Score
-14 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
144638
Genie Therapeutics develops gene therapy technologies with the aim of assisting patients in restoring and regenerating their skin.
- Aaron Tabor: Founder, CEO
About the Company
Genie Therapeutics develops gene therapy technologies with the aim of assisting patients in restoring and regenerating their skin.
Established in 2007 by Dr. Tabor, GENIE Therapeutics envisions utilizing gene transfer for the purpose of healing, restoring, and regenerating the skin. The company is centered around patented, 3rd generation non-viral
gene therapy technologies, with a primary focus on delivering therapeutics to enable countless patients to rejuvenate and transform their skin, regaining their youthfulness. The team boasts extensive expertise in the field and a strong commitment to utilizing gene therapies to bring about significant enhancements in skin health.
